Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Carboplatin|BIOLOGICAL: Nivolumab|BIOLOGICAL: Cabiralizumab|PROCEDURE: Tumor biopsy|PROCEDURE: Bone marrow|PROCEDURE: Blood draw
Sponsor: Washington University School of Medicine
Collaborators: Bristol-Myers Squibb